A centrosome clustering suspect, HSET, is a potential biomarker for breast cancer aggressiveness in triple-negative breast cancer (TNBC) patients

Cantuaria, Guilherme

412 - Poster Session B
A centrosome clustering suspect, HSET, is a potential biomarker for breast cancer aggressiveness in triple-negative breast cancer (TNBC) patients

Sunday, March 23, 2014: 6:40 AM

West Exhibit Hall (Tampa Convention Center)

G. Cantuaria¹, V. Pannu², S. Pawar², P. C. G. Rida², M. V. Gupta³ and R. Aneja²
¹Northside Hospital, Atlanta, GA, ²Georgia State University, Atlanta, GA, ³West Georgia Medical Center, LaGrange, GA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

412 - Poster Session B
A centrosome clustering suspect, HSET, is a potential biomarker for breast cancer aggressiveness in triple-negative breast cancer (TNBC) patients

412 - Poster Session B A centrosome clustering suspect, HSET, is a potential biomarker for breast cancer aggressiveness in triple-negative breast cancer (TNBC) patients

412 - Poster Session B
A centrosome clustering suspect, HSET, is a potential biomarker for breast cancer aggressiveness in triple-negative breast cancer (TNBC) patients